| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/16/2011 | US7998474 Methods for treating an inflammatory disease of the bowel |
| 08/16/2011 | US7997079 Self-regulated thermal energy system |
| 08/16/2011 | CA2646209C Use of strobilurins for treating malfunctions of the iron metabolism |
| 08/16/2011 | CA2493423C Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis following vascular injury |
| 08/16/2011 | CA2487095C Elongase genes and uses thereof |
| 08/16/2011 | CA2382941C Use of leptin in inhibition of endothelial cell proliferation |
| 08/11/2011 | WO2011097456A2 Compositions and methods for enhanced parvovirus transduction |
| 08/11/2011 | WO2011097317A1 Use of n1,n4-bis[3-(ethylamino)propyl]-2-butene-1,4-diamine compounds in combination with epigenetic-acting pharmaceuticals for enhanced cancer therapy |
| 08/11/2011 | WO2011096490A1 Imidazopyridin-2-one derivative |
| 08/11/2011 | WO2011096484A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | WO2011096377A1 Pyrrole compound |
| 08/11/2011 | WO2011095604A1 Half-life prolongation of proteins |
| 08/11/2011 | WO2011095049A1 Optically active 2-hydroxy tetrahydrothienopyridine derivatives, preparation method and use in manufacture of medicament thereof |
| 08/11/2011 | WO2011077455A3 Development of an effective herbal drug formulation for the treatment of sickle cell disease and the process thereof |
| 08/11/2011 | US20110196128 Murine zcytor17 ligand polynucleotides |
| 08/11/2011 | US20110195997 Dicarboxamide Derivatives |
| 08/11/2011 | US20110195976 Compounds derived from 2-(3-methylenedioxy)-benzoyl indol |
| 08/11/2011 | US20110195928 Administration of Copper to an Animal |
| 08/11/2011 | US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS |
| 08/11/2011 | US20110195055 Method and apparatus for holding cells |
| 08/11/2011 | CA2824869A1 Optically active 2-hydroxytetrahydrothienopyridine derivatives, preparation method and use in manufacture of medicament thereof |
| 08/11/2011 | CA2788730A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | CA2788682A1 Compositions and methods for enhanced parvovirus transduction |
| 08/10/2011 | EP2352815A1 Method for producing platelets |
| 08/10/2011 | EP1496873B2 Chewable soft capsule |
| 08/10/2011 | EP1190074B1 Recombinant anti-cd40 antibody and uses thereof |
| 08/10/2011 | CN1817906B Antibody against human parathormone related peptides |
| 08/10/2011 | CN102149389A Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| 08/10/2011 | CN102146364A Serine protease isolated from the venom of bombus ignitus as fibrinogenolytic and fibrinolytic enzymes |
| 08/10/2011 | CN102146334A Donkey-hide gelatin wine |
| 08/10/2011 | CN102146074A Preparation method of pyrrole derivative and application thereof |
| 08/10/2011 | CN102145103A Traditional Chinese medicine composition for warming and invigorating kidney yang and replenishing qi to promote diuresis and preparation method thereof |
| 08/10/2011 | CN102145102A Traditional Chinese medicinal composition for warming and tonifying kidney yang and strengthening qi and promoting diuresis and preparation method thereof |
| 08/10/2011 | CN102145067A Traditional Chinese medicine capsule for treating bone marrow suppression caused by highly active antiretroviral therapy (HAART) for AIDS (acquired immure deficiency syndrome) |
| 08/10/2011 | CN102145063A Traditional Chinese medicine for treating thrombocytopenic purpura |
| 08/10/2011 | CN102145055A Sugar-free embolism eliminating oral liquid and preparation method thereof |
| 08/10/2011 | CN102144995A Use of 5,6,7,4'-tetra-acetoxyl flavone for preparing medicine for preventing and curing cardiovascular and cerebrovascular diseases |
| 08/10/2011 | CN102144994A Antiplatelet aggregative activity of compound extracted from dalbergia wood |
| 08/10/2011 | CN102144986A Potassium chloride cyclopenthiazide sustained release tablet and preparation method thereof |
| 08/10/2011 | CN102144974A Liposome preparation for anticoagulant thrombolytic difunctional fusion protein and preparation method thereof |
| 08/10/2011 | CN102144970A Alprostadil lipid nanosphere injection and preparation method thereof |
| 08/10/2011 | CN102144961A Transscleral delivery |
| 08/10/2011 | CN102144958A Notoginsenoside-containing medicinal toothpaste and preparation method thereof |
| 08/10/2011 | CN101974068B Tanshinon IIA crylic acid or sodium salt thereof, preparation method and application thereof |
| 08/10/2011 | CN101804119B Traditional Chinese medicine preparation for treating thrombocytopenia and preparation method thereof |
| 08/10/2011 | CN101797335B Chinese medicinal composition for treating functional uterine bleeding |
| 08/10/2011 | CN101497557B Method for extracting purified solanesol from potato leaf |
| 08/10/2011 | CN101327235B Use of pseudo-ginseng saponins for treating septicemia |
| 08/10/2011 | CN101085802B Method for preparing Notoginsen triterpenes |
| 08/10/2011 | CN101011499B Linaloe leaf extract, pharmaceutical and health care uses thereof |
| 08/09/2011 | US7994346 such as methyl 2-({(4S,5R)-5-[(1E,3E,7E)-(S)-10-(4-fluorophenoxy)-9-hydroxydeca-1,3,7-trien-5-yn-1-yl]-2,2-dimethyl-1,3-dioxolan-4-yl}methoxy)acetate, useful in treating inflammatory and autoimmune disorders in humans |
| 08/09/2011 | US7994318 Coumarin derivatives useful as TNFα inhibitors |
| 08/09/2011 | US7994292 MU-1, member of the cytokine receptor family |
| 08/09/2011 | US7994198 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 08/09/2011 | US7994125 Administered before,during or after chemotherapy |
| 08/09/2011 | US7994117 Thrombopoietic compounds |
| 08/09/2011 | US7993896 Streptomyces griseoplanus α-galactosidases for removing immunodominant α-galactose monosaccharides from blood group B or AB reactive cells |
| 08/09/2011 | US7993643 Using low density lipoprotein receptor specific immunoglobulin for treatment and prevention of athersclerotic, kidney and inflammatory disorders |
| 08/09/2011 | CA2688709C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 08/09/2011 | CA2688695C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 08/09/2011 | CA2688694C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 08/09/2011 | CA2687924C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 08/09/2011 | CA2634664C Novel albumin-free factor viii formulations |
| 08/09/2011 | CA2537092C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 08/09/2011 | CA2447921C Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 08/09/2011 | CA2441492C Rho-kinase inhibitors |
| 08/09/2011 | CA2438595C Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
| 08/09/2011 | CA2432568C Benzoylpyridazines |
| 08/09/2011 | CA2334941C Tnf-derived peptides for use in treating oedema |
| 08/09/2011 | CA2293415C Compositions for treating and preventing arterial thrombosis and use of a factor xa inhibitor on its own and/or combined with a platelet antiaggregating agent |
| 08/04/2011 | WO2011094496A2 Trypsin-like serine protease inhibitors, and their preparation and use |
| 08/04/2011 | US20110190342 Glycine b antagonist |
| 08/04/2011 | US20110190339 6-substituted isoquinolines and isoquinolinones |
| 08/04/2011 | US20110190316 Substituted pyridines, and use thereof as Gsk3 inhibitors |
| 08/04/2011 | US20110190308 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| 08/04/2011 | US20110190287 Thrombocyte Inhibition Via Vivo-Morpholino Knockdown of Alpha IIB |
| 08/04/2011 | US20110190277 Pharmaceutical combination for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 08/04/2011 | US20110190270 Methods of treating thromboembolic disorders |
| 08/04/2011 | US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor |
| 08/04/2011 | US20110190209 Conjugates having a releasable linkage |
| 08/04/2011 | US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 08/04/2011 | US20110189279 Pharmaceutical compositions with modified release properties comprising 5-chloro-n-(-methyl)-2-thiophencarboxamid |
| 08/04/2011 | US20110189211 Stem cell populations and methods of use |
| 08/04/2011 | US20110189190 Anti-hepcidin-25 selective antibodies and uses thereof |
| 08/04/2011 | US20110189182 Proteolytically cleavable fusion proteins with high molar specific activity |
| 08/04/2011 | US20110189166 Methods of treating hemorheologic abnormalities in mammals |
| 08/04/2011 | US20110189160 Veterinary Topical Agent |
| 08/04/2011 | US20110189152 Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency |
| 08/04/2011 | US20110189151 Compositions and methods for prolonging survival of platelets |
| 08/04/2011 | US20110189139 Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 Polypeptide |
| 08/04/2011 | US20110189120 Aegyptin and uses thereof |
| 08/04/2011 | US20110189082 Human gm-csf antigen binding proteins |
| 08/04/2011 | CA2788417A1 Trypsin-like serine protease inhibitors, and their preparation and use |
| 08/03/2011 | EP2351749A1 Carbamate compound or salt thereof |
| 08/03/2011 | EP2351562A1 Solid solution of valine, isoleucine and leucine, and method for producing same |
| 08/03/2011 | EP2351556A2 Encapsulated functional fine particle composition capable of spraying and preparation method thereof |
| 08/03/2011 | EP2351483A1 Prevention and treatment of blood coagulation-related diseases |
| 08/03/2011 | EP2350051A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators |
| 08/03/2011 | EP2350048A2 Azine derivatives and methods of use thereof |
| 08/03/2011 | EP2349996A1 1-phenylpyrrole compounds |